On Tuesday, SELLAS Life Sciences Group Inc (NASDAQ: SLS) opened lower -4.00% from the last session, before settling in for the closing price of $1.25. Price fluctuations for SLS have ranged from $0.50 to $1.72 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 22.63%. Company’s average yearly earnings per share was noted 57.21% at the time writing. With a float of $64.06 million, this company’s outstanding shares have now reached $64.33 million.
Let’s determine the extent of company efficiency that accounts for 16 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
SELLAS Life Sciences Group Inc (SLS) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of SELLAS Life Sciences Group Inc is 0.43%, while institutional ownership is 6.31%.
SELLAS Life Sciences Group Inc (SLS) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted -0.33 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at 0.03) by -0.36. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 57.21% per share during the next fiscal year.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Trading Performance Indicators
Check out the current performance indicators for SELLAS Life Sciences Group Inc (SLS). In the past quarter, the stock posted a quick ratio of 1.02.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.92, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach -0.46 in one year’s time.
Technical Analysis of SELLAS Life Sciences Group Inc (SLS)
Looking closely at SELLAS Life Sciences Group Inc (NASDAQ: SLS), its last 5-days average volume was 0.67 million, which is a drop from its year-to-date volume of 1.11 million. As of the previous 9 days, the stock’s Stochastic %D was 60.88%. Additionally, its Average True Range was 0.07.
During the past 100 days, SELLAS Life Sciences Group Inc’s (SLS) raw stochastic average was set at 43.82%, which indicates a significant decrease from 54.17% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 34.05% in the past 14 days, which was lower than the 62.72% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2522, while its 200-day Moving Average is $1.1486. However, in the short run, SELLAS Life Sciences Group Inc’s stock first resistance to watch stands at $1.2733. Second resistance stands at $1.3467. The third major resistance level sits at $1.3833. If the price goes on to break the first support level at $1.1633, it is likely to go to the next support level at $1.1267. Now, if the price goes above the second support level, the third support stands at $1.0533.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Key Stats
There are currently 57,755K shares outstanding in the company with a market cap of 77.20 million. Presently, the company’s annual sales total 0 K according to its annual income of -37,340 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -7,470 K.
